We found that many of the metabolites implicated in our study were elevated in 5/6 nephrectomy rodent models of CKD, indicating that these gut-derived and OAT1-mediated metabolites can be altered in the setting of diminished renal function (28). Here, SLC22A6 is linked to chronic kidney disease.